A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

被引：0
|
作者：
Midori Nakagaki
Michael Barras
Cameron Curley
Jason P. Butler
Glen A. Kennedy
机构：
[1] Royal Brisbane and Women’s Hospital,Pharmacy Department, Level 1 Ned Hanlon Building
[2] The University of Queensland,Bone Marrow Transplant Unit, Level 5 Joyce Tweddell Building
[3] Royal Brisbane and Women’s Hospital,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Stem cell transplantation; Antiemetics; Ondansetron; Palonosetron; Olanzapine; Nausea and vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [21] Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
    Gralla, R
    Lichinitser, M
    Van der Vegt, S
    Sleeboom, H
    Mezger, J
    Peschel, C
    Tonini, G
    Labianca, R
    Macciocchi, A
    Aapro, M
    ANNALS OF ONCOLOGY, 2003, 14 (10) : 1570 - 1577
  • [22] The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Veerisa Vimolchalao
    Siwat Sakdejayont
    Ploytuangporn Wongchanapai
    Shama Sukprakun
    Pattama Angspatt
    Wilai Thawinwisan
    Piyachut Chenaksara
    Virote Sriuranpong
    Chanida Vinayanuwatikun
    Napa Parinyanitikun
    Nattaya Poovorawan
    Suebpong Tanasanvimon
    International Journal of Clinical Oncology, 2020, 25 : 396 - 402
  • [23] Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial
    Clemmons, Amber B.
    Orr, Julianne
    Andrick, Benjamin
    Gandhi, Arpita
    Sportes, Claude
    DeRemer, David
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (10) : 2065 - 2071
  • [24] Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis
    Hsu, Yu-Chen
    Chen, Ching-Yao
    Tam, Ka-Wai
    Hsu, Chin-Yu
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (11) : 1597 - 1609
  • [25] The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Vimolchalao, Veerisa
    Sakdejayont, Siwat
    Wongchanapai, Ploytuangporn
    Sukprakun, Shama
    Angspatt, Pattama
    Thawinwisan, Wilai
    Chenaksara, Piyachut
    Sriuranpong, Virote
    Vinayanuwatikun, Chanida
    Parinyanitikun, Napa
    Poovorawan, Nattaya
    Tanasanvimon, Suebpong
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 396 - 402
  • [26] A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
    Aapro, M. S.
    Grunberg, S. M.
    Manikhas, G. M.
    Olivares, G.
    Suarez, T.
    Tjulandin, S. A.
    Bertoli, L. F.
    Yunus, F.
    Morrica, B.
    Lordick, F.
    Macciocchi, A.
    ANNALS OF ONCOLOGY, 2006, 17 (09) : 1441 - 1449
  • [27] A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients
    Yeo, Winnie
    Lau, Thomas K. H.
    Li, Leung
    Lai, Kwai Tung
    Pang, Elizabeth
    Cheung, Maggie
    Chan, Vicky T. C.
    Wong, Ashley
    Soo, Winnie M. T.
    Yeung, Vanessa T. Y.
    Tse, Teresa
    Lam, Daisy C. M.
    Yeung, Eva W. M.
    Ng, Kim P. K.
    Tang, Nelson L. S.
    Tong, Macy
    Suen, Joyce J. S.
    Mo, Frankie K. F.
    BREAST, 2020, 50 : 30 - 38
  • [28] Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC)
    Hesketh, Paul J.
    Morrow, Gary
    Komorowski, Anna W.
    Ahmed, Raza
    Cox, David
    SUPPORTIVE CARE IN CANCER, 2012, 20 (10) : 2633 - 2637
  • [29] Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
    Kang, Jin Hyoung
    Kwon, Jung Hye
    Lee, Yun-Gyoo
    Park, Keon Uk
    An, Ho Jung
    Sohn, Joohyuk
    Seol, Young Mi
    Lee, Hyunwoo
    Yun, Hwan-Jung
    Ahn, Jin Seok
    Yang, Ji Hyun
    Song, Hunho
    Koo, Dong-Hoe
    Kim, Jin Young
    Kim, Gun Min
    Kim, Hwa Jung
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 907 - 916
  • [30] Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study
    Sandip Mukhopadhyay
    Gagandeep Kwatra
    Pamela Alice K
    Dinesh Badyal
    Supportive Care in Cancer, 2017, 25 : 145 - 154
12345